Cubist Pharmaceuticals may have added some punch to its antibiotics portfolio by buying Optimer Pharmaceuticals a few months ago, but as is often the case with M&A deals, the buyout is also precipitating a lot of job cuts. The Jersey Journal reported today that Cubist is laying off as many as 177 employees of Jersey … Continue reading “Layoffs Hit Optimer Following Cubist Buyout”
Category: Boston
East Coast Biotech Roundup: Juno, Editas, Celgene, & More
The holidays are in full swing, as are some big startup ideas that have had the biotech world buzzing over the past few weeks. Those stories and more as the roundup returns from a Thanksgiving break: —Juno Therapeutics earned the distinction this week of having one of the largest bets ever placed on a biotech … Continue reading “East Coast Biotech Roundup: Juno, Editas, Celgene, & More”
High-Tech Holidays: The Xperience Gift Guide, 2013 Edition
Wait, what? Cyber Monday was four days ago, and you still haven’t finished your holiday gift buying? Don’t worry, we haven’t either. But we thought we’d take some time away from our busy shopping schedules to help you find the best presents for the gadget geeks in your life. In the slideshow above, we’ve collected … Continue reading “High-Tech Holidays: The Xperience Gift Guide, 2013 Edition”
Claritas Genomics Garners Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7c6b14ea-5091-4376-bbeb-9ceec2758f21 Date 12/6/2013 Company Name Claritas Genomics Mailing Address 99 Erie Street Cambridge, MA 02139 Company Description Claritas is a full-service CLIA Genetic Diagnostic Laboratory, originally part of Boston Children’s Hospital. It was launched as a stand-alone entity in February 2013 and is designed to meet the genetic testing needs of ordering … Continue reading “Claritas Genomics Garners Series A Round”
SmartCloud Receives $3,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da778c76-b8d7-4d42-9190-be11b3f17c1d Date 12/6/2013 Company Name SmartCloud Mailing Address 19 Crosby Dr. Bedford, MA 01730 Company Description SmartCloud, Inc. was founded in 2009 by four veterans of the process control and artificial intelligence industries. Our mission is to become a leading provider of real-time Big Reasoning solutions for mission critical environments and the … Continue reading “SmartCloud Receives $3,000,000 New Financing Round”
LiveClips Secures New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eb260d55-5b76-4f26-b5e3-ec079bbabc19 Date 12/6/2013 Company Name LiveClips Mailing Address One Landmark Square 14th Floor Stamford, CT 06901 Company Description LiveClips is an innovator and leader in the development and delivery of video content from live sporting events to any Internet-enabled device. Website http://www.liveclips.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Undisclosed … Continue reading “LiveClips Secures New Funding”
FDA’s Culture Is Genetically Dominant Over 23andMe’s Business Model
I’ve been following the 23andMe saga with dread and fascination and frustration since it hit in late November. If you’re not up to date, David Dobbs has the canonical collection of stories to get you there. This is a post about business models and culture clashes. It’s long. I should also start by disclosing that my former … Continue reading “FDA’s Culture Is Genetically Dominant Over 23andMe’s Business Model”
An Innovative Cleantech Strategy: Invest in Solar PV for Nonprofits
For decades we’ve been led to believe that donating money is the only way to financially support a nonprofit organization committed to a mission we care about. However, what if there was a different way to support nonprofits that could also provide a modest financial return? Perhaps the biggest challenge for nonprofits that want to … Continue reading “An Innovative Cleantech Strategy: Invest in Solar PV for Nonprofits”
TripAdvisor CEO Kaufer: Reinvent the Company in Good Times
Yes, TripAdvisor. You use it. I use it. But do you know the man behind this popular travel site? And why he is leading a major push to revitalize the company? Founder and CEO Steve Kaufer (pictured) keeps a relatively low profile around town. That’s the way he likes it, but he probably wouldn’t mind … Continue reading “TripAdvisor CEO Kaufer: Reinvent the Company in Good Times”
Toyota Licenses Wireless Battery Charging Tech from WiTricity
Toyota is getting more serious about wireless charging for its electric cars, and a Boston-area company is benefitting. The world’s largest car-maker says it is licensing patents from Watertown, MA-based WiTricity, an MIT spinout that has developed technology to recharge batteries without using wires. The two companies didn’t say how much money the deal is … Continue reading “Toyota Licenses Wireless Battery Charging Tech from WiTricity”
A Tablet App from Invention Labs Helps Kids with Speech Disabilities
The field of educational technologies is going through an exciting period. From massively open online courses (MOOCs) like MIT’s OCW or edX and Khan Academy to a range of tablet and smartphone applications, the field is rife with exciting innovations that have dramatically changed the face of education. There is a higher degree of self-learning … Continue reading “A Tablet App from Invention Labs Helps Kids with Speech Disabilities”
DealerRater Lands $25,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3be7f819-8234-444e-ae7b-1da5931ccc79 Date 12/5/2013 Company Name DealerRater Mailing Address 203 Crescent St. Waltham, MA 02453 Company Description DealerRater established the first car dealer review website worldwide to help you find the right automotive dealer online when purchasing or servicing your car. We provide the opportunity for you to search for car dealerships, read … Continue reading “DealerRater Lands $25,000,000 New Funding”
Technical Machine Secures $1,000,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=592ef7ac-ba46-4c4b-8783-7a04b2722780 Date 12/5/2013 Company Name Technical Machine Mailing Address MB 729 1000 Olin Way Needham, MA 02492 Company Description Technical Machine seeks to empower software developers to make the next generation of physical, internet-enabled devices- from prototype to manufacturing. Website http://www.tessel.io Transaction Type Venture Equity Transaction Amount $1,000,000 Transaction Round Seed Proceeds … Continue reading “Technical Machine Secures $1,000,000 Seed Round”
Disruptor Beam Obtains $820,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=79a10a66-0ef0-4694-90d9-8d843e4a2675 Date 12/5/2013 Company Name Disruptor Beam Mailing Address 711 Atlantic Ave Lower Level Boston, MA 02111 Company Description We are a Boston-based game company that transports the fans of beloved literary and television series into the worlds they love. By linking game content to episodes and books, players become a living … Continue reading “Disruptor Beam Obtains $820,000 New Round”
Soft Tissue Regeneration Garners $4,702,526 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8bd81d23-cf84-4b0e-ae87-e296ea14420c Date 12/5/2013 Company Name Soft Tissue Regeneration Mailing Address 142 Temple Street New Haven, CT 06510 Company Description Soft Tissue Regeneration has developed and preliminarily tested a potential breakthrough technology for soft tissue regeneration of the anterior cruciate ligament of the knee. Website http://www.softtissueregeneration.com Transaction Type Venture Equity Transaction Amount $4,702,526 … Continue reading “Soft Tissue Regeneration Garners $4,702,526 New Funding Round”
Boston Roundup: Volition Capital, Freight Farms, Technical Machine
A few notable fundraising deals: —Volition Capital, a spinout from Boston-based Fidelity Investments’ venture operation, has finished raising its second growth equity fund at more than $170 million. The firm, led by co-founder and managing partner Larry Cheng, showed up in the news this summer when it filed SEC paperwork for the first $80 million … Continue reading “Boston Roundup: Volition Capital, Freight Farms, Technical Machine”
Healthcare Gets Personal on Dec. 12 at Google: Here’s the Agenda
I first met George Church in the Connecticut backyard of literary agent John Brockman. It was 2007, and Church, the genomics pioneer, was giving an informal talk on synthetic biology. Afterwards, he got stung by some sort of weird-looking bee. The event stuck in my mind. Here’s hoping next Thursday, Dec. 12, will be just … Continue reading “Healthcare Gets Personal on Dec. 12 at Google: Here’s the Agenda”
Zafgen Corrals $45M More to Fuel Obesity Drug Push
Zafgen is just weeks removed from some encouraging results from a mid-stage clinical trial of its obesity drug candidate, beloranib. Now it’s parlayed those numbers into another big raise from investors. Cambridge, MA-based Zafgen today snagged a $45 million Series E round from a group of both private and public investors—typically a sign that a … Continue reading “Zafgen Corrals $45M More to Fuel Obesity Drug Push”
NYCEDC Amassing $100M Biotech Fund; Boehringer Jumps Into Kendall Square
Boston’s biotech cluster is light years ahead of the one the Big Apple is hoping to form. But the two geographic rivals are both getting help from big pharmaceutical companies to bolster their respective life sciences ecosystems. In Manhattan, the New York City Economic Development Corp., a local government entity, and three big life sciences … Continue reading “NYCEDC Amassing $100M Biotech Fund; Boehringer Jumps Into Kendall Square”
Exploros Garners $500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0b388949-da26-428f-8bc0-26107927d542 Date 12/4/2013 Company Name Exploros Mailing Address PO Box 81 Wayland, MA 01778 Company Description The Exploros Team has both experienced and shaped the progression of educational technology. We began with LOGAL software’s flagship product line—a breakthrough simulation-based science and math curriculum. Website http://www.exploros.com Transaction Type Debt, Crowdfunder Transaction Amount $500,000 … Continue reading “Exploros Garners $500,000 New Round”
Exploros Garners $500,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0b388949-da26-428f-8bc0-26107927d542 Date 12/4/2013 Company Name Exploros Mailing Address PO Box 81 Wayland, MA 01778 Company Description The Exploros Team has both experienced and shaped the progression of educational technology. We began with LOGAL software’s flagship product line—a breakthrough simulation-based science and math curriculum. Website http://www.exploros.com Transaction Type Debt, Crowdfunder Transaction Amount $500,000 … Continue reading “Exploros Garners $500,000 New Financing”
Zafgen Secures $45,000,000 Series E Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=19f872df-5cd3-496d-a575-45e3bda772de Date 12/4/2013 Company Name Zafgen Mailing Address One Broadway 8th Floor Cambridge, MA 02142 Company Description The company is developing novel therapeutics for the treatment of obesity. Website http://www.zafgen.com Transaction Type Venture Equity Transaction Amount $45,000,000 Transaction Round Series E Proceeds Purposes Proceeds from the financing will be used to support … Continue reading “Zafgen Secures $45,000,000 Series E Financing Round”
Misfit Wearables Secures $15,200,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e7b82ef9-279d-4ee1-9ac7-ff974dd008c7 Date 12/4/2013 Company Name Misfit Wearables Mailing Address 411 Massachusetts Avenue Cambridge, MA 02139 Company Description We are developing highly wearable sensor products and services for wellness and medical applications. Website http://www.misfitwearables.com Transaction Type Venture Equity Transaction Amount $15,200,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms … Continue reading “Misfit Wearables Secures $15,200,000 New Funding Round”
Superpedestrian Starts Selling “Copenhagen Wheel” Electric Bike Kits
At first glance, this square-faced building about a mile from the MIT campus doesn’t look like the kind of place that’s fixing the future of urban transportation. Not until the doors swing open and a guy zips into the street, piloting a bike that sports a big red disc affixed to the rear wheel. This … Continue reading “Superpedestrian Starts Selling “Copenhagen Wheel” Electric Bike Kits”
Modern Day Scrooges Are Ruining Our Health Care System
More than a 150 years ago Charles Dickens’ A Christmas Carol introduced the character Ebenezer Scrooge, who was the embodiment of greed, “tight-fisted…. a squeezing, wrenching, grasping, scraping, clutching, covetous, old sinner! Hard and sharp as flint, from which no steel had ever struck out generous fire.” If Dickens were alive today he’d recognize that … Continue reading “Modern Day Scrooges Are Ruining Our Health Care System”
Akamai to Acquire Security Company Prolexic for $370M
Akamai is beefing up its defenses against Internet attackers. The Cambridge, MA-based network company, best known for handling about a third of the Web’s traffic globally, is paying $370 million to acquire Prolexic, a Web security company. Prolexic sells security software that protects data centers and big-business Internet applications from distributed denial of service (DDoS) … Continue reading “Akamai to Acquire Security Company Prolexic for $370M”
Financial Apps Will Make People Smarter and More Open About Money
Socially acceptable topics of conversation are always evolving. It’s no longer uncommon to hear discussions about religion and politics at the dinner table. However, there’s still one incredibly important issue that most people would just as soon sweep under the rug: finances. When was the last time you had a detailed conversation with your spouse, … Continue reading “Financial Apps Will Make People Smarter and More Open About Money”
3 Life Sciences Companies That Are Built to Last
Lots of biotech companies today say they want to be great for a long, long time. But which of today’s companies are actually doing it? Which ones are truly visionary, and built to last? These questions have been on my mind since I re-read “Built to Last: Successful Habits of Visionary Companies” in preparation for … Continue reading “3 Life Sciences Companies That Are Built to Last”
Visterra Adds $8M, Ex-Amag Execs, To Begin Clinical Push for Flu Antibody
Visterra has spent four years designing and fine-tuning an antibody that it thinks can combat all types of influenza. Now it’s pocketed some cash and filled out a revamped management team to take that drug into the clinic. Cambridge, MA-based Visterra has added $8.1 million in venture dollars to its bank account, representing the third … Continue reading “Visterra Adds $8M, Ex-Amag Execs, To Begin Clinical Push for Flu Antibody”
Visterra Obtains $8,100,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=36ecff47-ea68-43a5-9cc3-a0f9540bdd3f Date 12/2/2013 Company Name Visterra Mailing Address One Kendall Square Cambridge, MA 02139 Company Description Visterra, Inc. is dedicated to the discovery and development of innovative products for the prevention, treatment and diagnosis of infectious diseases. The Company focuses on technologies that can interrogate how pathogens interact with human cells, a … Continue reading “Visterra Obtains $8,100,000 Series A Financing”
Yahoo! Acquires SkyPhrase for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0a1023aa-e9db-4118-9ef8-119d08975b55 Date 12/2/2013 Company Name SkyPhrase Mailing Address Undisclosed Boston, MA 02101 Company Description SkyPhrase has made breakthroughs in algorithms that enable computers to understand more complex language with greater precision than has ever been possible. Our technology also makes it extremely easy for developers with no experience in linguistics or artificial … Continue reading “Yahoo! Acquires SkyPhrase for Undisclosed Sum”
LogicSource Receives $7,993,476 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9e82d263-b24a-4df5-9306-bb2a9b2d5948 Date 11/29/2013 Company Name LogicSource Mailing Address 20 Marshall Street South Norwalk, CT 06854 Company Description We focus exclusively on the procurement of printed materials and related commodities and services. In partnership with Bain Capital, we have built our company with the singular vision of driving measurable and sustainable cost savings … Continue reading “LogicSource Receives $7,993,476 New Financing”
It’s Time to Play Moneyball: The Investment Readiness Level
Investors sitting through Incubator or Accelerator demo days have three metrics to judge fledgling startups – 1) great looking product demos, 2) compelling PowerPoint slides, and 3) a world-class team. We think we can do better. We now have the tools, technology and data to take incubators and accelerators to the next level. Teams can … Continue reading “It’s Time to Play Moneyball: The Investment Readiness Level”
Boston Roundup: Care.com, Sonian, QD Vision, Rest Devices
—Care.com, a Waltham, MA-based operator of Web search services for finding babysitters and other personal service providers, has reportedly filed secret paperwork for an IPO. The Wall Street Journal has that report, citing anonymous sources, part of the new routine for IPOs under secret filing provisions of the Jobs Act. Care.com has raised some $110 … Continue reading “Boston Roundup: Care.com, Sonian, QD Vision, Rest Devices”
Is This the End of Premium Pricing in Drug and Device Innovation?
Healthcare costs in the United States today account for approximately 18 percent of our gross domestic product—far more than any other developed country. Americans’ average life expectancy and the efficiency of our healthcare system are ranked near the bottom of countries with advanced economies. It’s not just a healthcare problem, either. It’s an economic problem. … Continue reading “Is This the End of Premium Pricing in Drug and Device Innovation?”
Gridco Systems Secures $9,999,992 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4c5aef75-0761-46fd-8a35-144d6c110425 Date 11/27/2013 Company Name Gridco Systems Mailing Address 10-L Commerce Way Woburn, MA 01801 Company Description Gridco Systems’ products are helping to build the distribution grid of the future – one that is more efficient, reliable and capable of integrating renewable generation and electric vehicles at high penetration rates. Website http://www.gridcosystems.com … Continue reading “Gridco Systems Secures $9,999,992 New Round”
23andMe: Victim of an Overboard FDA Crackdown, or Provocateur?
Last Friday, the Food and Drug Administration issued a warning letter to the direct-to-consumer genetic testing company 23andMe ordering it to stop marketing its Personal Genome Service. According to the FDA, the 23andMe genetic test is a medical device, and subject to intense regulation before it can be marketed, because “it is intended for use … Continue reading “23andMe: Victim of an Overboard FDA Crackdown, or Provocateur?”
DraftKings Rounds Up $24M for Fantasy Sports Games
It’s kind of a no-brainer that running a gambling business can make you money. But the laws around that industry are, shall we say, a bit restrictive. There’s also a bit of social backlash to contend with—just ask the people who wanted to plant new casinos outside of Boston, only to see voters respond with … Continue reading “DraftKings Rounds Up $24M for Fantasy Sports Games”
Gates Foundation Health Chief on Coaxing Pharma to Do Good (Part 2)
Yesterday, I ran the first installment of an interview with Trevor Mundel, the president of global health at the Seattle-based Bill & Melinda Gates Foundation. He talked about his personal reasons for leaving the pharmaceutical industry to work on global health problems, and how the foundation makes decisions on how to spend its money. Today, … Continue reading “Gates Foundation Health Chief on Coaxing Pharma to Do Good (Part 2)”
Aphios Secures $50,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=88194078-ebf4-477c-958c-0815fd67c8a7 Date 11/26/2013 Company Name Aphios Mailing Address 3-E Gill Street Woburn, MA 01801 Company Description We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System … Continue reading “Aphios Secures $50,000 New Financing Round”
Aphios Garners $50,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=88194078-ebf4-477c-958c-0815fd67c8a7 Date 11/26/2013 Company Name Aphios Mailing Address 3-E Gill Street Woburn, MA 01801 Company Description We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System … Continue reading “Aphios Garners $50,000 New Financing”
Ancera Garners $1,277,500 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f71e500-170c-4662-8412-0dc754e91f3b Date 11/26/2013 Company Name Ancera Mailing Address 21 Business Park Drive Branford, CT 06405 Company Description The company is developing a rapid, portable technology platform for the separation, quantitative detection and identification of minute concentrations of various pathogens from whole blood or other bodily fluids. Ancera’s platform is based on technology … Continue reading “Ancera Garners $1,277,500 New Funding”
Sonian Receives $8,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3c7e66a5-c876-498a-b397-4980e748fd42 Date 11/26/2013 Company Name Sonian Mailing Address 3 Allied Drive Dedham, MA 02026 Company Description Sonian is a technology platform and hosted services company on a mission to help millions of organizations world-wide manage their critical IT functions such as archiving, search, compliance, e-discovery and storage management. The Sonian platform is … Continue reading “Sonian Receives $8,000,000 New Funding Round”
Editas Medicine Obtains $43,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7ec95543-d669-42f8-b38d-8300f05b444b Date 11/26/2013 Company Name Editas Medicine Mailing Address Undisclosed Cambridge, MA 02138 Company Description Editas Medicine is a Cambridge, Massachussetts-based biotech startup. Website Undisclosed Transaction Type Venture Equity Transaction Amount $43,000,000 Transaction Round Series A Proceeds Purposes The cash will be used to get the platform ready for prime time, and … Continue reading “Editas Medicine Obtains $43,000,000 Series A Financing”
DraftKings Receives $24,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bc2ee8cc-1417-401f-af14-ac635d13da22 Date 11/26/2013 Company Name DraftKings Mailing Address 47 Winter Street 3rd Floor Boston, MA 02108 Company Description DraftKings, which was recently named one of “Five you should follow” by Mass High Tech’s Startup Watch, allows people to not only play for one day, but they can bet through the website and … Continue reading “DraftKings Receives $24,000,000 Series B Financing Round”
Cubist’s Calixa Buyout Bears Fruit as Antibiotic Hits First Phase 3 Mark
When Cubist Pharmaceuticals (NASDAQ: [[ticker:CBST]]) agreed to shell out as much as $402.5 million for Calixa Therapeutics a few years ago, this was the type of day it had in mind. Lexington, MA-based Cubist said today that the antibiotic it acquired in the Calixa buyout, CXA-201, hit its mark in the first of two Phase … Continue reading “Cubist’s Calixa Buyout Bears Fruit as Antibiotic Hits First Phase 3 Mark”
The Future of Data and Devices: The Photos
D2 is in the books. Our “Future of Data and Devices” tech conference on Thursday delivered on its promise to stir up discussion of where big data, the cloud, and connected devices are converging—and how entrepreneurs and innovators can stay ahead of the curve. What did we learn? Here are four of my broad takeaways: … Continue reading “The Future of Data and Devices: The Photos”
What Entrepreneurs Should Learn from John Lackey
Success in business is out of reach to those who aren’t already blessed with plentiful advantage, so goes the conventional wisdom. A similar stereotype in sports is that you either have talent or you don’t. But the story of a once-maligned pitcher’s World Series victory upends both of these stereotypes, and has great lessons for … Continue reading “What Entrepreneurs Should Learn from John Lackey”
Gates Foundation Health Chief on Coaxing Pharma to Do Good
Bill Gates can summon the CEOs of every major global pharmaceutical company, and get them thinking and talking about things that won’t help them make more money. Pharma and biotech companies, cast as the villain pretty much everywhere, certainly like the PR boost they get from working with Gates and putting their immense resources to … Continue reading “Gates Foundation Health Chief on Coaxing Pharma to Do Good”
Three VCs Pour $43M Into Editas to “Edit” Out Genetic Disorders
Gene therapy, make way for gene “editing.” Today, three of Boston’s biotech startup creators—Polaris Partners, Third Rock Ventures, and Flagship Ventures, have banded together to create a new, Cambridge, MA-based startup called Editas Medicine. It’s a sizable bet. The three, with the help of Partners Innovation Fund, have plunked down a $43 million Series A … Continue reading “Three VCs Pour $43M Into Editas to “Edit” Out Genetic Disorders”